PENUMBRA SYSTEM 3MAX SEPARATOR
Report
- Report Number
- 3005168196-2014-00398
- Event Type
- Injury
- Date Received
- June 18, 2014
- Date of Event
- July 1, 2013
- Report Date
- May 19, 2014
- Manufacturer
- PENUMBRA, INC.
- Product Code
- NRY
- PMA / PMN Number
- K113163
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- JA
- Reporter Occupation
- PHYSICIAN
Narratives
CONCLUSION: HEMORRHAGE IS A KNOWN AND ANTICIPATED COMPLICATION WITH THESE TYPES OF PROCEDURES AND IS NOTED IN THE DEVICE LABELING. THEREFORE, IT WAS DETERMINED THAT THE REPORTED EVENT WAS AN ANTICIPATED PROCEDURAL COMPLICATION. THE MANUFACTURING RECORDS FOR THIS LOT WERE REVIEWED AND DID NOT REVEAL ANY OUTSTANDING DISCREPANCIES, DESIGN, OR QUALITY CONCERNS. THIS MDR IS ASSOCIATED WITH MDR 3005168196-2014-00397. DEVICE WAS DISPOSED OF BY THE HOSPITAL.
THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE IN THE LEFT MIDDLE CEREBRAL ARTERY (MCA - M2) USING A PENUMBRA SYSTEM 3MAX REPERFUSION CATHETER AND A 3MAX SEPARATOR. BEFORE THE PROCEDURE, INTRAVENOUS TISSUE PLASMINOGEN WAS NOT ADMINISTERED. DURING THE PROCEDURE, A 3MAX REPERFUSION CATHETER WAS ADVANCED TO THE M2 ALONG WITH ANOTHER MANUFACTURER'S GUIDE WIRE AND GUIDING CATHETER. ASPIRATION WAS DONE WITH A 3MAX SEPARATOR AND 5,500 UNITS OF HEPARIN WERE INJECTED. A POST-OPERATIVE COMPUTED TOMOGRAPHY (CT) INDICATED THAT THE PATIENT WAS FOUND TO HAVE SUBARACHNOID HEMORRHAGE (SAH) AND HAD SEVERAL SYMPTOMATIC EPILEPTIC SEIZURES. THE PHYSICIAN CLOSELY MONITORED THE PATIENT'S CONDITION BUT WITHHELD ANY ADDITIONAL TREATMENT. APPROXIMATELY A MONTH LATER, THE PATIENT RECOVERED. PHYSICIAN'S COMMENT: SINCE THE SAH OCCURRED AROUND THE TARGET VESSEL, THE RELATION BETWEEN THE EVENT AND THE PENUMBRA SYSTEM WAS NOT DENIAL. THE EVENT WAS RELATED TO THE PROCEDURE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 358664 | PENUMBRA SYSTEM 3MAX SEPARATOR | NRY | NRY | PENUMBRA, INC. | F33660 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 84 YR | Other |